| Amarin

A preliminary proxy statement providing notification matters to be brought to a vote

Submitted by amarin on Mon, 02/12/2024 - 13:04

Read more about A preliminary proxy statement providing notification matters to be brought to a vote

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/09/2024 - 21:34

Read more about Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/09/2024 - 21:34

Read more about Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/09/2024 - 21:34

Read more about Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/02/2024 - 21:35

Read more about Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/02/2024 - 21:35

Read more about Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Submitted by amarin on Fri, 02/02/2024 - 21:35

Read more about Statement of changes in beneficial ownership of securities

Report of unscheduled material events or corporate event

Submitted by amarin on Fri, 01/26/2024 - 12:03

Read more about Report of unscheduled material events or corporate event

Statement of changes in beneficial ownership of securities

Submitted by amarin on Wed, 01/24/2024 - 21:34

Read more about Statement of changes in beneficial ownership of securities

Amarin Chairman & CEO Issue Letter to Shareholders

Submitted by amarin on Mon, 01/22/2024 - 12:30

Read more about Amarin Chairman & CEO Issue Letter to Shareholders

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Chairman of the Board, Odysseas Kostas, M.D., and President & CEO, Patrick Holt, issued the following letter to Amarin shareholders: Dear Fellow Amarin